Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas F Larson

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Critical Care (London, England)|May 9, 2006
Macrophage migration inhibitory factor: controller of systemic inflammationDouglas F Larson, Katherine Horak
Perfusion|November 18, 2009
CardioWest temporary total artificial heartAnthony Platis, Douglas F Larson
The Journal of Extra-Corporeal Technology|September 1, 2004
Rationale of platelet gel to augment adaptive remodeling of the injured heartChristopher Mogan, Douglas F Larson
Perfusion|May 28, 2005
Inflammatory cytokine inhibition of erythropoiesis in patients implanted with a mechanical circulatory assist deviceChristopher N Pierce, Douglas F Larson
The Journal of Extra-Corporeal Technology|August 23, 2006
Hyperglycemia as an effect of cardiopulmonary bypass: intra-operative glucose managementSamira Najmaii, Daniel Redford, Douglas F Larson
Perfusion|November 21, 2007
Insulin binding to the cardiopulmonary bypass biomaterialsKristyn Urban, Daniel Redford, Douglas F Larson
Perfusion|January 10, 2008
Effect of acute alpha adrenergic stimulation on cardiac functionStacy Dunaway, Qianli Yu, Douglas F Larson
Hypertension (Dallas, Tex. : 1979)|June 1, 2006
Role of T lymphocytes in hypertension-induced cardiac extracellular matrix remodelingQianli Yu, Katherine Horak, Douglas F Larson
The Journal of Extra-Corporeal Technology|November 24, 2004
Stem cells for regeneration of cardiac tissues: current findings and future applicationsKatherine Horak, Victoria Dotson, Douglas F Larson
Plos One|April 18, 2013
Biphasic change of tau (τ) in mice as arterial load acutely increased with phenylephrine injectionBo Yang, Douglas F Larson, James Ranger-Moore
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Critical Care (London, England)|May 9, 2006
Macrophage migration inhibitory factor: controller of systemic inflammationDouglas F Larson, Katherine Horak
Perfusion|November 18, 2009
CardioWest temporary total artificial heartAnthony Platis, Douglas F Larson
The Journal of Extra-Corporeal Technology|September 1, 2004
Rationale of platelet gel to augment adaptive remodeling of the injured heartChristopher Mogan, Douglas F Larson
Perfusion|May 28, 2005
Inflammatory cytokine inhibition of erythropoiesis in patients implanted with a mechanical circulatory assist deviceChristopher N Pierce, Douglas F Larson
The Journal of Extra-Corporeal Technology|August 23, 2006
Hyperglycemia as an effect of cardiopulmonary bypass: intra-operative glucose managementSamira Najmaii, Daniel Redford, Douglas F Larson
Perfusion|November 21, 2007
Insulin binding to the cardiopulmonary bypass biomaterialsKristyn Urban, Daniel Redford, Douglas F Larson
Perfusion|January 10, 2008
Effect of acute alpha adrenergic stimulation on cardiac functionStacy Dunaway, Qianli Yu, Douglas F Larson
Hypertension (Dallas, Tex. : 1979)|June 1, 2006
Role of T lymphocytes in hypertension-induced cardiac extracellular matrix remodelingQianli Yu, Katherine Horak, Douglas F Larson
The Journal of Extra-Corporeal Technology|November 24, 2004
Stem cells for regeneration of cardiac tissues: current findings and future applicationsKatherine Horak, Victoria Dotson, Douglas F Larson
Plos One|April 18, 2013
Biphasic change of tau (τ) in mice as arterial load acutely increased with phenylephrine injectionBo Yang, Douglas F Larson, James Ranger-Moore
Pageof 5